19:33:59 EDT Thu 03 Jul 2025
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 41,327,425
Close 2024-12-12 C$ 0.085
Market Cap C$ 3,512,831
Recent Sedar Documents

Ndatalyze releases CMCP-D module on EMR platforms

2024-12-12 18:18 ET - News Release

Mr. Jim Durward reports

NDATALYZE CORP. ANNOUNCES ITS AI-BASED DEPRESSION ASSESSMENT AVAILABILITY THROUGH THE LARGEST CANADIAN ELECTRONIC MEDICAL RECORD ("EMR ") PLATFORMS

Ndatalyze Corp.'s objective AI (artifical intelligence) based comprehensive mental condition probability -- depression (CMCP-D) module is now available via the three largest Canadian electronic medical records (EMR) platforms, the offerings of which feature integration of, or connection to, the OceanMD Forms platform. In Canada alone, the largest EMR platforms collectively service more than 60,000 physicians. According to PerplexityAI, 93 per cent of Canadian physicians and over 80 per cent of U.S. office-based physicians use EMR systems to manage patient relations.

James Durward, president, commented: "This availability is a huge step forward toward widespread adoption of our advanced AI-based mental condition prediction system. While the depression assessment is only one of our mental condition assessments, we already have four more objective AI-based assessments in the migration queue. We have also received interest from [United States]-based EMRs regarding native integration of our CMCP system."

The company further announces that its YMI system is being rebranded and will now be referred to CMCP-5 (comprehensive mental condition probabilities). Changes to its website are continuing.

About CMCP-5

CMCP-5 uses evidence-based, objective data from whole life experiences to predict individual mental states over time, and applies this knowledge toward a fuller understanding of how mental health develops and how to improve mental well-being. CMCP-5 combines expert-guided machine learning with a proprietary reference database to predict an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies and targeting key markets, CMCP-5 aligns societal impact with financial success.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.